Ningbo Sanxing Medical Electric Co.,Ltd. (SHA:601567)
China · Delayed Price · Currency is CNY 14.65
+0.69 (4.94%)
Jun 12, 2026, 3:00 PM CST
SHA:601567 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 20,502 | 32,348 | 43,405 | 28,947 | 18,980 | 22,615 | |
Market Cap Growth | -41.76% | -25.47% | 49.94% | 52.52% | -16.07% | 145.26% |
Enterprise Value | 21,372 | 33,094 | 42,589 | 28,281 | 18,585 | 22,231 |
Last Close Price | 14.65 | 22.79 | 28.70 | 18.79 | 12.02 | 14.07 |
PE Ratio | 21.77 | 25.39 | 19.21 | 15.21 | 20.02 | 32.77 |
Forward PE | 8.10 | 25.04 | 25.04 | 25.04 | 25.04 | 25.04 |
PS Ratio | 1.47 | 2.25 | 2.97 | 2.53 | 2.09 | 3.22 |
PB Ratio | 1.72 | 2.75 | 3.54 | 2.60 | 1.97 | 2.53 |
P/TBV Ratio | 2.04 | 3.28 | 4.32 | 3.19 | 2.39 | 2.90 |
P/FCF Ratio | 17.97 | 38.88 | 54.83 | 21.52 | 23.18 | - |
P/OCF Ratio | 10.60 | 18.26 | 23.64 | 15.23 | 15.52 | 113.68 |
EV/Sales Ratio | 1.53 | 2.30 | 2.92 | 2.47 | 2.04 | 3.17 |
EV/EBITDA Ratio | 14.14 | 20.27 | 14.63 | 14.27 | 14.11 | 29.88 |
EV/EBIT Ratio | 20.17 | 25.01 | 16.17 | 16.36 | 17.07 | 40.50 |
EV/FCF Ratio | 18.73 | 39.78 | 53.80 | 21.02 | 22.70 | - |
Debt / Equity Ratio | 0.51 | 0.53 | 0.36 | 0.31 | 0.14 | 0.21 |
Debt / EBITDA Ratio | 4.06 | 3.52 | 1.44 | 1.69 | 0.96 | 2.44 |
Debt / FCF Ratio | 5.38 | 7.49 | 5.52 | 2.60 | 1.59 | - |
Net Debt / Equity Ratio | 0.05 | 0.02 | -0.08 | -0.18 | -0.17 | -0.14 |
Net Debt / EBITDA Ratio | 0.45 | 0.15 | -0.34 | -1.01 | -1.26 | -1.66 |
Net Debt / FCF Ratio | 0.54 | 0.29 | -1.26 | -1.49 | -2.03 | 12.80 |
Asset Turnover | 0.56 | 0.57 | 0.64 | 0.61 | 0.59 | 0.49 |
Inventory Turnover | 2.45 | 2.49 | 2.61 | 3.01 | 4.39 | 5.88 |
Quick Ratio | 1.21 | 1.30 | 1.21 | 1.27 | 1.08 | 1.34 |
Current Ratio | 1.89 | 1.88 | 1.77 | 1.79 | 1.45 | 1.63 |
Return on Equity (ROE) | 7.52% | 10.39% | 19.41% | 18.49% | 10.40% | 7.99% |
Return on Assets (ROA) | 2.66% | 3.29% | 7.16% | 5.73% | 4.38% | 2.40% |
Return on Invested Capital (ROIC) | 6.59% | 8.99% | 21.95% | 17.16% | 11.64% | 6.12% |
Return on Capital Employed (ROCE) | 5.90% | 7.30% | 15.80% | 11.80% | 10.30% | 5.50% |
Earnings Yield | 4.64% | 3.94% | 5.21% | 6.58% | 5.00% | 3.05% |
FCF Yield | 5.56% | 2.57% | 1.82% | 4.65% | 4.31% | -0.43% |
Dividend Yield | 4.30% | 2.76% | 3.10% | 3.46% | 2.91% | 2.27% |
Payout Ratio | 210.63% | 156.37% | 42.18% | 26.90% | 52.27% | 83.18% |
Buyback Yield / Dilution | -0.22% | -0.24% | -0.14% | 0.35% | -2.54% | 0.40% |
Total Shareholder Return | 4.08% | 2.53% | 2.96% | 3.81% | 0.38% | 2.68% |